Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Authors in the psilocybin and psilocin literature
Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.
Publication history
Phase 1 trial suggests benefit of psilocybin in OCD treatmentThe Brown University Psychopharmacology Update · 2026-07-31Psilocybin shows mixed results for patients with treatment-resistant depressionThe Brown University Psychopharmacology Update · 2026-05-28Single-dose psilocybin with CBT more effective than nicotine patch for smoking cessationThe Brown University Psychopharmacology Update · 2026-05-28Control group improvement lower in psilocybin trials for depressionThe Brown University Psychopharmacology Update · 2025-10-09Synaptic priming: A framework for pharmacotherapy in depression.Unknown journal · 2025-10-07Reply to Gattuso et al.: "Comments on 'Striking long-term beneficial effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 rodent model of OCD-like excessive self-grooming' by Brownstien et al. (2024)".Unknown journal · 2025-09-02Response to emotional stimuli weaker in SSRI users compared with psilocybinThe Brown University Psychopharmacology Update · 2025-08-03204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDERThe International Journal of Neuropsychopharmacology · 2025-07-31551. PSYCHEDELICS AND OCD: TRANSLATIONAL APPROACHESThe International Journal of Neuropsychopharmacology · 2025-07-31Synthesis of Psilocin, Psilocybin and 5-MeO-DMT Succinate, All Labelled With Carbon-14 at the Indole 2-PositionJournal of Labelled Compounds and Radiopharmaceuticals · 2025-06-30Psilocybin-assisted therapy shows range of benefits in cancer patientsThe Brown University Psychopharmacology Update · 2025-04-28Trial finds psilocybin improves symptoms in treatment-resistant depressionThe Brown University Psychopharmacology Update · 2025-04-28Psilocybin-assisted therapy leads to personality shifts in patients with alcohol use disorderThe Brown University Psychopharmacology Update · 2025-03-26Psilocybin therapy might help frontline pandemic workersThe Brown University Psychopharmacology Update · 2025-03-02A qualitative analysis of the psychedelic mushroom come-up and come-downnpj Mental Health Research · 2025-02-06Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.Unknown journal · 2025-01-29Long-term effects of single-dose psilocybin and psychedelic mushroom extract in the SAPAP3 model of OCD-like behaviorNeuroscience Applied · 2024-12-31ALSUntangled #77: Psilocybin.Unknown journal · 2024-12-21Review of trials finds psychedelics generally well-toleratedThe Brown University Psychopharmacology Update · 2024-11-04Premorbid Characteristics of the SAPAP3-Mouse Model of Obsessive-Compulsive Disorder: Behavior, Neuroplasticity, and Psilocybin TreatmentbioRxiv · 2024-09-22Mystical Experience with Cancer Patients: Insights from Psychedelic-Assisted Psychotherapy and Guided ImageryClinical Endocrinology and Metabolism · 2024-08-29Striking Long Term Beneficial Effects of Single Dose Psilocybin and Psychedelic Mushroom Extract in the SAPAP3 Rodent Model of OCD-Like Excessive Self-GroomingbioRxiv · 2024-06-28Review identifies factors associated with response to psilocybinThe Brown University Psychopharmacology Update · 2024-06-26Survey finds new users of psychedelics report unusual visual experiencesThe Brown University Psychopharmacology Update · 2024-03-03Patients with bipolar II disorder benefit from single dose of psilocybinThe Brown University Psychopharmacology Update · 2024-03-03Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.Unknown journal · 2024-02-29The Temporal Trajectory of the Psychedelic Mushroom Experience Mimics the Narrative Arc of the Hero’s JourneyResearch Square · 2024-02-22Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary FindingsPsychedelic Medicine · 2023-11-30Single dose of psilocybin improves depressive symptoms in Phase 2 studyThe Brown University Psychopharmacology Update · 2023-10-29Psilocybin shows promising results in subjects continuing to use an antidepressantThe Brown University Psychopharmacology Update · 2023-10-03Perceptions of psychedelic-assisted therapy among Black AmericansJournal of Mood and Anxiety Disorders · 2023-09-25Psilocybin, escitalopram have comparable effects on personality in patients with depressionThe Brown University Psychopharmacology Update · 2023-09-02Acute effects of psilocybin, LSD, mescaline found to be similarThe Brown University Psychopharmacology Update · 2023-09-02Single-Dose Psilocybin Treatment for Major Depressive DisorderJAMA · 2023-08-30Letter to the editor on "Increased low-frequency brain responses to music after psilocybin therapy for depression".Unknown journal · 2023-05-28Bedside to bench: the outlook for psychedelic research.Frontiers in pharmacology · 2022-12-31High dose of psilocybin effective for treatment-resistant depressionThe Brown University Psychopharmacology Update · 2022-12-26History of epilepsy increases risk of psychedelic-induced seizuresThe Brown University Psychopharmacology Update · 2022-12-09Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 Receptors in the Head Twitch Response Induced by 5-Hydroxytryptophan and Psilocybin: Translational Implications.International Journal of Molecular Sciences · 2022-11-15Psilocybin-assisted therapy reduces heavy drinking in patients with AUDThe Brown University Psychopharmacology Update · 2022-11-02The Use of Psychedelics in the Treatment of Medical Conditions: An Analysis of Currently Registered Psychedelics Studies in the American Drug Trial Registry.Cureus · 2022-08-31Role of 5-HT2A, 5-HT2C, 5-HT1A and TAAR1 receptors in the head twitch response induced by 5-hydroxytryptophan and psilocybin: Translational implicationsbioRxiv · 2022-07-22Synapses, predictions, and prediction errors: a neocortical computational study of MDD using the temporal memory algorithm of HTMbioRxiv · 2022-07-02Trial of psilocybin does not show major difference from antidepressantThe Brown University Psychopharmacology Update · 2021-07-04Low Doses of Psilocybin and Ketamine Enhance Motivation and Attention in Poor Performing Rats: Evidence for an Antidepressant Property.Frontiers in Pharmacology · 2021-02-25Study: Psilocybin enhances therapy in patients with major depressionThe Brown University Psychopharmacology Update · 2021-01-06Data justify further research on potential of psychedelics in treating psychiatric disordersThe Brown University Psychopharmacology Update · 2020-05-05Entheogens in Christian art: Wasson, Allegro, and the Psychedelic GospelsJournal of Psychedelic Studies · 2019-05-31High dose psilocybin is associated with positive subjective effects in healthy volunteers.Journal of Psychopharmacology · 2018-06-26Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.Clinical Pharmacokinetics · 2017-11-30Qualitative and Quantitative Features of Music Reported to Support Peak Mystical Experiences during Psychedelic Therapy Sessions.Frontiers in Psychology · 2017-07-24